0.4 mg
Trade Name
Tamosymp
Modified-release capsule, hard
Request Type
Registration
Drug Type
Generic(Multisource) Drug
Approval Date
SFDA Approved Use
Lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH)